References
- Stanford. Medicine, Center for Definitive and Curative Medicine. Why cell and gene therapy? Available at https://med.stanford.edu/cdcm/CGT.html. Accessed January 31, 2024.
- EuroGCT. What conditions can currently be treated using gene and cell therapy? Available at https://www.eurogct.org/what-conditions-can-currently-be-treated-using-gene-and-cell-therapy. Accessed January 31, 2024.
- Horrow C, Kesselheim AS. Confronting high costs and clinical uncertainty: innovative payment models for gene therapies. Health Aff (Millwood). 2023;42(11):1532–1540. doi:10.1377/hlthaff.2023.00527.
- Nazareth T, Ko JJ, Sasane R, et al. Outcomes-based contracting experience: research findings from U.S. and european stakeholders. J Manag Care Spec Pharm. 2017;23(10):1018–1026. doi:10.18553/jmcp.2017.23.10.1018.
- Centers for Medicare & Medicaid Services. Cell and gene therapy (CGT) access model. Available https://www.cms.gov/priorities/innovation/innovation-models/cgt. Accessed March 1, 2024.
- American Society of Gene + Cell Therapy. Gene and cell therapy FAQ's. Available at https://asgct.org/education/more-resources/gene-and-cell-therapy-faqs#. Accessed January 31, 2024.
- US Food and Drug Administration. FDA approves first cell-based gene therapy for adult patients with multiple myeloma. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-first-cell-based-gene-therapy-adult-patients-multiple-myeloma. Accessed January 31, 2024.
- US Food and Drug Administration. FDA approves first gene therapy to treat adults with hemophilia B. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treat-adults-hemophilia-b. Accessed January 31, 2024.
- US Food and Drug Administration. FDA approves first cellular therapy to treat patients with type 1 diabetes. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-first-cellular-therapy-treat-patients-type-1-diabetes#. Accessed on. January 31, 2024.
- GuyCarpenter. Gene and cell therapies: navigating the challenges around rising costs in medical insurance. Available https://www.guycarp.com/insights/2023/09/gene-cell-therapies-navigating-challenges-around-rising-costs-in-medical-insurance.html#. Accessed April 12, 2024.
- US Food and Drug Administration. FDA approves first gene therapies to treat patients with sickle cell disease. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease. Accessed January 31, 2024.
- Lin K. Will the high price of gene therapy for sickle cell disease put this cure out of reach? Available at https://www.aafp.org/pubs/afp/afp-community-blog/entry/will-the-high-price-of-gene-therapy-for-sickle-cell-disease-put-this-cure-out-of-reach.html. Accessed January 31, 2024.
- KFF. State Medicaid Participation in Interstate Purchasing Pools for Prescription Drugs. Available https://www.kff.org/other/state-indicator/state-medicaid-participation-in-interstate-purchasing-pools-for-prescription-drugs/. Accessed March 20, 2024.